Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Mirum Pharmaceuticals (MIRM) Return on Assets (2020 - 2025)

Historic Return on Assets for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Q3 2025 value amounting to 0.05%.

  • Mirum Pharmaceuticals' Return on Assets rose 1000.0% to 0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05%, marking a year-over-year increase of 1000.0%. This contributed to the annual value of 0.13% for FY2024, which is 1900.0% up from last year.
  • According to the latest figures from Q3 2025, Mirum Pharmaceuticals' Return on Assets is 0.05%, which was up 1000.0% from 0.08% recorded in Q2 2025.
  • Over the past 5 years, Mirum Pharmaceuticals' Return on Assets peaked at 0.05% during Q3 2025, and registered a low of 0.74% during Q3 2021.
  • For the 5-year period, Mirum Pharmaceuticals' Return on Assets averaged around 0.29%, with its median value being 0.25% (2022).
  • Per our database at Business Quant, Mirum Pharmaceuticals' Return on Assets skyrocketed by 6100bps in 2022 and then crashed by -2700bps in 2023.
  • Over the past 5 years, Mirum Pharmaceuticals' Return on Assets (Quarter) stood at 0.32% in 2021, then fell by -19bps to 0.38% in 2022, then soared by 33bps to 0.25% in 2023, then skyrocketed by 48bps to 0.13% in 2024, then skyrocketed by 58bps to 0.05% in 2025.
  • Its Return on Assets was 0.05% in Q3 2025, compared to 0.08% in Q2 2025 and 0.11% in Q1 2025.